MELBOURNE, AUSTRALIA / ACCESSWIRE / November 18, 2024 / Immuron Limited (NASDAQ:IMRN) has one commercial product and two pipeline assets in three clinical programs for the treatment of gut mediated ...

Immuron Limited (AU:IMC) has released an update. Immuron Limited announced that all resolutions at its recent Annual General Meeting were ...

Immuron Limited (AU:IMC) has released an update. Immuron Limited has reported a significant 172% increase in global sales, reaching $4.90 ...